BioSpace News Archive

Metagenomi to Present Preclinical In Vivo and Ex Vivo Gene-Editing Data at the 63rd American Society of Hematology (ASH) Annual Meeting.

Shasqi, a clinical-stage biotechnology company developing precision activated oncology therapeutics with its proprietary Click Activated Protodrugs Against Cancer Platform, announced that it has been awarded a second ‘Direct to Phase 2’ Small Business Innovation Research grant from the National Cancer Institute.

Tranquis Therapeutics today announced the initiation of dosing in a Phase 1 clinical study of TQS-168 in healthy volunteers.

Virpax ® Pharmaceuticals, Inc. reported positive results following the completion of a toxicology and pharmacokinetic study designed to support clinical trials with Epoladerm™, one of its lead investigational product candidates for the management of pain associated with osteoarthritis of the knee.

Aytu BioPharma, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to AR101 (enzastaurin) for the treatment of Ehlers-Danlos Syndrome.

Tessera Therapeutics Adds New Executives to its Leadership Team as the Company Continues to Pioneer Gene Writing ™ Technology as New Category in Genetic Medicine.

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) in collaboration with researchers from Florida International University’s Department of Physics and Biomolecular Sciences Institute, today announced the publication of a study entitled “Lipid II Binding and Transmembrane Properties of Various Antimicrobial Lanthipeptides.”

H3 Biomedicine Inc. today announced the presentation of two posters at the 2021 San Antonio Breast Cancer Symposium (SABCS) being held in a hybrid format on December 7- 10, 2021.

PerkinElmer, Inc. today announced the research use only (RUO) launch of the NEXTFLEX ® Variant-Seq™ SARS-CoV-2 Kit v2 to accelerate the detection of SARS-CoV-2 variants.

Actinium Pharmaceuticals, Inc. announced today its participation in the Targeted Radiopharmaceuticals Summit being held virtually December 7 – 9, 2021.